These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6763088)

  • 1. [Expectorants].
    Nagaoda S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Nov; 20(11):1119-23. PubMed ID: 6763088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Qualitatively reliable study proves: in chronic bronchitis or COPD--standardized Myrtol].
    MMW Fortschr Med; 2004 May; 146(19):56-7. PubMed ID: 15357482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of various expectorants on sputum viscoelasticity in vivo (author's transl)].
    Shimura S; Sato S; Aoki T; Takishima T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Mar; 18(3):161-70. PubMed ID: 7392320
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of expectorant agents].
    Galsanov Shch B
    Sov Med; 1987; (12):100-5. PubMed ID: 3328304
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucus-controlling agents: past and present.
    King M; Rubin BK
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyto-diagnostic test results following sputum provocation with Bisolvon].
    Fischnaller M; Schwarzenberg E; Wrbka E
    Wien Klin Wochenschr; 1967 Jan; 79(1):1-3. PubMed ID: 5340279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences in parenteral treatment with a broncho-secretolytic agent].
    Marquardt R
    Med Monatsschr; 1966 Jul; 20(7):322-4. PubMed ID: 5927494
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood gas studies in a double-blind technic with Bisolvon].
    Michel CF
    Ther Umsch; 1965 Jul; 22(7):360-1. PubMed ID: 5319618
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is therapy for lung diseases with secretolytics useful?].
    Gillissen A
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1237. PubMed ID: 19472097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of the cough sedative, expectorant and eupneic properties of the preparation, "Cardiazol-Paracodin" Knoll].
    Bini P; Romagnoli E
    Minerva Med; 1971 Feb; 62(17):837-41. PubMed ID: 5551772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mucolytics. Our experience].
    Perriconi HM; Castagneto H
    Prensa Med Argent; 1967 Apr; 54(6):287-9. PubMed ID: 5613949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acetylcysteine in children with lung disorders prescribed by one third of family physicians; no support in the literature].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1997 Aug; 141(31):1542. PubMed ID: 9543745
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK
    Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial mucolytic agents].
    Leuenberger P
    Rev Med Suisse Romande; 1996 May; 116(5):335-9. PubMed ID: 8693268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acetylcysteine prescribed by one third of family physicians for lung diseases in children; no proof in the literature].
    Meyboom-de Jong B
    Ned Tijdschr Geneeskd; 1997 Jun; 141(24):1212-3. PubMed ID: 9380161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expectorant and liquescent preparations in the therapy of bronchial asthma and nonspecific lung diseases and their prevention].
    Komarov FI; Daniliak IG; Guliaeva FE; Mindlina GI; Zhukova AV
    Klin Med (Mosk); 1980 Apr; 58(4):19-24. PubMed ID: 6991798
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R; de Jongste JC; Merkus PJ
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.